Beyond Air, Inc. Common Stock (XAIR) is a publicly traded Healthcare sector company. As of May 21, 2026, XAIR trades at $0.40 with a market cap of $6.11M and a P/E ratio of -0.57. XAIR moved +0.00% today. Year to date, XAIR is -51.15%; over the trailing twelve months it is -89.56%. Its 52-week range spans $0.38 to $13.52. Analyst consensus is buy with an average price target of $2.00. Rallies surfaces XAIR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
XAIR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. XAIR recently traded at $0.40. Market cap is $6.11M. P/E ratio is -0.57. Revenue is $3.71M.
| Metric | Value |
|---|---|
| Price | $0.40 |
| Market Cap | $6.11M |
| P/E Ratio | -0.57 |
| EPS | $-0.69 |
| Dividend Yield | 0.00% |
| 52-Week High | $13.52 |
| 52-Week Low | $0.38 |
| Volume | 15.09K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.71M |
| Net Income | $-48.48M |
| Gross Margin | -44.88% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $3.71M | $-48.48M | $-0.69 |
| 2024 | $-1.31M | $-64.30M | $-1.82 |
| 2023 | $-555.00K | $-59.40M | $-1.86 |
| 2022 | $0 | $-44.06M | $-1.68 |
2 analysts cover XAIR: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.00.